IFNG and neoplasm: On one hand, IFN−γ binds to its receptor and activates the JAK/STAT pathway, leading to the production and activation of IRF−1 and subsequent modulation of programmed cell death ligand−1 (PD−L1) expression in tumor cells (20, 21).